plasma and whole blood pharmacokinetics of epirubicin ( 4'-epidoxorubicin , epidx ) , a new doxorubicin ( dx ) analogue with an improved spectrum of activity and lower toxicity , were investigated in advanced cancer patients after i.v . bolus administration .
C0014582
4
C0013089
doxorubicin